The topic Medication-Induced Autoimmune Hepatitis you are seeking is a synonym, or alternative name, or is closely related to the medical condition Drug-Induced Autoimmune Hepatitis.

Quick Summary:

• Autoimmune hepatitis (AIH) is an autoimmune disease of unknown cause that results in the body’s own immune system attacking the liver. When this happens, abnormal inflammation characteristic of hepatitis occurs, causing damage to the liver. The condition is mostly seen in females
• Drug-Induced Autoimmune Hepatitis (DIAH or DIAIH) occurs secondary to the use of certain medication, as an adverse reaction of the body. DIAH is most often caused by medications, such as minocycline, nitrofurantoin, and propylthiouracil, among others; a majority of the cases are noted in women
• Drug-Induced Autoimmune Hepatitis and autoimmune hepatitis have many overlapping features; but, experts believe that these two conditions are distinct clinical entities. Also, it is difficult to differentiate between DIAH and autoimmune hepatitis caused by other factors such as diabetes mellitus, celiac disease, Hashimoto's thyroiditis, and inflammatory bowel disease
• A definitive diagnosis of Drug-Induced Autoimmune Hepatitis may be arrived at only on the analysis of clinical findings, thorough medical history, lab tests, and recent medication use history. The signs and symptoms are similar to autoimmune hepatitis and may include yellowing of the skin, nausea, vomiting, loss of appetite, and abdominal pain
• Stopping or discontinuing the use of such medications may decrease progression of Drug-Induced Autoimmune Hepatitis and/or may result in resolution of the condition. Unlike autoimmune hepatitis, the prognosis of DIAH is reported to be excellent in a vast majority of cases with adequate treatment

Please find comprehensive information on Drug-Induced Autoimmune Hepatitis regarding definition, distribution, risk factors, causes, signs & symptoms, diagnosis, complications, treatment, prevention, prognosis, and additional useful information HERE.